Peter G. Steinherz, MD

Director, Leukemia and Lymphoma Studies
Peter G. Steinherz, MD -- Director, Leukemia and Lymphoma Studies

I am a pediatric hematologist and oncologist who treats cancers that occur in infants, children, and young adults. My research efforts are focused on the study of the biology of leukemia, lymphoma, and Wilms' tumor, and on the development of new therapies that improve the long-term survival of patients with these cancers.

For more than 35 years here at Memorial Sloan Kettering, I have directed the administration of therapy to children and adolescents with leukemia. During this time, my colleagues and I developed new treatment protocols, including the New York I and New York II protocols, which are now used as the standard of care all over the world. These protocols have improved the survival of patients with acute lymphoblastic leukemia (ALL) — the most common cancer in children — from 50 percent in the 1970s to more than 80 percent for high-risk, and more than 90% for standard-risk patients today.

Appointments for New Patients
Clinical Expertise

Pediatric Oncology; Leukemias; Lymphomas: Hodgkin and non-Hodgkin Lymphoma; Wilms’ Tumor; Developmental Chemotherapy

Languages Spoken

MD, Albert Einstein College of Medicine


The New York Hospital/Cornell Medical Center


Cornell University Medical College

Board Certifications

Pediatrics; Pediatric Hematology-Oncology

See My Colleagues in:
Publications by Peter G. Steinherz
Visit PubMed for full listing of Peter G. Steinherz journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.